CRDL Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cardiol Therapeutics Inc (CRDL) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of significant positive catalysts, weak financial performance, and no clear trading signals suggest holding off on investing in this stock right now.
The MACD is positive and expanding, indicating a bullish trend. However, RSI is in the neutral zone at 70.294, and moving averages are converging, which does not provide a strong directional signal. Key resistance levels are at 1.102 and 1.155, while support levels are at 0.928 and 0.874.
The MACD histogram is positive and expanding, suggesting a potential upward momentum.
No significant news or event-driven catalysts. Financial performance is weak with declining net income and EPS. No recent insider or hedge fund activity. Congress trading data is unavailable.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped by -21.72% YoY to -9,964,281, and EPS fell by -33.33% YoY to -0.12. Gross margin remained at 0, showing no improvement.
No recent analyst ratings or price target changes are available for this stock.
